Simplex Trading’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-12
Closed 11018
2022
Q3
$0 Buy
12
+10
+500% +$120 ﹤0.01% 11349
2022
Q2
$0 Sell
2
-17
-89% -$235 ﹤0.01% 11589
2022
Q1
$0 Sell
19
-1,061
-98% -$20.9K ﹤0.01% 11804
2021
Q4
$30K Sell
1,080
-1,313
-55% -$57.2K ﹤0.01% 7921
2021
Q3
$191K Hold
2,393
﹤0.01% 5677
2021
Q2
$190K Buy
+2,393
New +$200K ﹤0.01% 5767
2021
Q1
Sell
-12
Closed -$1K 10415
2020
Q4
$1K Buy
+12
New +$1.47K ﹤0.01% 8193
2020
Q2
Sell
-1
Closed 8632
2020
Q1
$0 Sell
1
-13
-93% -$2.12K ﹤0.01% 8511
2019
Q4
$4K Buy
+14
New +$2.82K ﹤0.01% 6822

Other funds holding ELOX

Simplex Trading's ELOX Position: Q4 2022 in Review

Simplex Trading sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q4 2022, closing a stake of 12 shares.

Simplex Trading first reported a position in ELOX in Q4 2019 and held it in 9 quarters. The position peaked at $191K in Q3 2021. 19 funds tracked by Wall St. Rank hold ELOX as of Q4 2022.

  • Simplex Trading reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Simplex Trading sold 12 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q4 2022.
  • Simplex Trading first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 9 quarters.
  • Simplex Trading's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $191K in Q3 2021.
  • 19 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.